Upgrade to Pro — share decks privately, control downloads, hide ads and more …

Integrative and interactive analyses of multi-omics data

Dc971cfc929cb925baf3d41f48e25fa5?s=47 Andrea Rau
July 02, 2020

Integrative and interactive analyses of multi-omics data

JOBIM 2020 keynote talk: The increased availability and affordability of high-throughput sequencing technologies in recent years has facilitated the use of multi-omic studies to expand and enrich our understanding of complex biological systems. However, defining a holistic and meaningful way to exploit these heterogeneous and multi-faceted ‘omics data can be complicated by several major obstacles. These include the unknown hierarchy and potentially ambiguous relationships among different sources of data, the explosion in data dimension, issues due to batch effects and quality control, potentially incomplete or missing data, limited sample sizes, and the occasional difficulty in posing well-defined and answerable research questions of such data. In light of these challenges, in this talk I will provide an overview of some of our methodological contributions to integrative multi-omic analyses, and I will discuss how the development of interactive tools can be a useful addition to the multi-omic analysis toolbox.

https://jobim2020.sciencesconf.org/

Dc971cfc929cb925baf3d41f48e25fa5?s=128

Andrea Rau

July 02, 2020
Tweet

Transcript

  1. Integrative and interactive analyses of multi-omics data ANDREA RAU JOBIM

    EVERYWHERE @ ZOOM JULY 2, 2020 1 https://andrea-rau.com @andreamrau slides: https://tinyurl.com/JOBIM2020-Rau
  2. 2 Gene expression TTTGCA AAACGT TF Transcription factor expression Copy

    number alterations The gene regulatory landscape and multi-omics data Promoter methylation microRNA expression …GCAGCGTTCGA… …GCAACGTTAGA… Somatic mutations Germline genetic variation Enhancer Accessibility Protein abundance Metabolite concentrations … + Histone modifications + RNA processing/stability + 3D conformation + Microbiome composition + …
  3. 3 - Comprehensive, multi-dimensional maps of key genomic changes in

    33 cancer types from 11k+ individuals ◦ RNA-seq, miRNA-seq, copy number alterations, methylation, somatic mutations, protein abundance, genotypes, histological data, clinical data - Publically available data (multi-tiered data depending on patient identifiability) - Widely used by the research community (1000+ publications by TCGA network + independent researchers) The Cancer Genome Atlas (TCGA) Image: Corces et al. (2018)
  4. 4 No regenerative response = disability Central nervous system (CNS)

    injury Study the gene regulatory network involved in CNS rewiring during optic nerve regeneration in zebrafish Robust regenerative response = functional recovery Gene expression + Chromatin accessibility (RNA-seq + ATAC-seq) Dhara et al. (2019) Scientific Reports; Rau et al. (2019) G3 4
  5. 5 - Many more biological entities than individuals (p >>

    n) - Experimental design - Normalization / standardization / pre-processing, potentially heterogenous quality across datasets, substantial batch effects - Missing or incomplete data (e.g., MI-MFA1) - Look-everywhere effect Some challenges of multi-omic data analysis https://bioinformatics.mdanderson.org/BatchEffectsViewer/ 1 Voillet et al. 2016; 2Ramos et al. (2017), https://bioconductor.org/packages/MultiAssayExperiment/ MultiAssayExperiment: coordinated representation + storage + analysis of multi-omics data2
  6. 6 - Horizontal versus vertical integration - Account for (known/unknown)

    interdependencies within and across data types - (Partially) matched omics data across samples or biological entities (e.g., genes) - In some contexts, limited/incomplete a priori knowledge of relevant phenotype groups for comparisons = unsupervised analysis Multi-omic data → Multivariate, multi-table methods Multi-{domain, way, view, modal, table, omics} data How do we integrate multi-omic data? What question are we specifically addressing? How can we use multi-omic data to answer that question? Image: Rajasundaram and Selbig (2016)
  7. 7 Broad umbrella of integrative data analysis Many different answers,

    depending on the question… Exploration / description • Find underlying relationships between datasets • Clustering, unsupervised classification Prediction • Identify small set of features (i.e., biomarkers) that yields best possible prediction • Remove noisy or redundant feature, curse of dimensionality • Use set of features to understand the underlying biology Causality • Extract mechanistic hypotheses and insights http://factominer.free.fr, http://mixomics.org/
  8. 8 For a given pathway of interest, can we identify

    and quantify highly aberrant individuals in a sample based on multi-omic data? Does patient prognosis correlate with large pathway deviation scores? Which individuals have the most aberrant profiles for pathways of interest? Which genes / omic drive these aberrant scores? Integrative multi-omics methods: Multivariate analysis
  9. A B C Individuals 1 / λA 1 / λB

    1 / λC Individuals 1 / λA 1 / λB 1 / λC PC 1 PC 2 ! 9 Define an individualized pathway-level deviation score based on multi-omic data using MFA http://github.com/andreamrau/padma Rau et al. (2020) Biostatistics, https://doi.org/10.1101/827022 padma: Pathway deviation scores using Multiple Factor Analysis i
  10. 10 Applying padma to TCGA multi-omics data Breast invasive carcinoma

    (BRCA; n = 504) and lung adenocarcinoma (LUAD; n = 144) • Batch correction performed using removeBatchEffects in limma • RNA-seq + promoter methylation + copy number alterations + miRNA-seq • miRNA → gene mapping provided by miRTarBase (exact matches, Functional MTI predictions) • 1136 MSigDB curated canonical pathways (Biocarta, PID, Reactome, Sigma Aldrich, Signaling Gateway, Signal Transduction Knowledge Environment, Matrisome Project) Patient prognosis measured using progression-free interval survival times (LUAD) and histological grade (BRCA) Rau et al. (2020) Biostatistics
  11. Which individuals have the most highly aberrant multi-omic profiles? 11

    D4-GDP dissociation inhibitor signaling pathway, LUAD (Cox PH*, BH padj = 0.0111) Rau et al. (2020) Biostatistics
  12. Which genes/omics drive large pathway deviation scores? 12 → CASP1,

    CASP3, and CASP8 all have high gene-level deviation scores for the two most extreme individuals… Rau et al. (2020) Biostatistics
  13. Which genes/omics drive large pathway deviation scores? 13 Rau et

    al. (2020) Biostatistics
  14. 14 • Larger padma deviation scores = increasingly aberrant pathway

    variation with significantly worse prognosis (survival, histological grade) in breast and lung cancer • Potential outlier detection tool Innovative use of existing MFA method to calculate and graphically explore individualized multi-omic pathway deviation scores Next steps… • Incorporation of known hierarchical structure among genes in pathway • Extensions for highly structured data (e.g., multi-omic data from divergent chicken lines subject to feed/heat stress or maize diversity panels under control/cold conditions) padma results on TCGA breast and lung cancer (RNA-seq + miRNA-seq + methylation + CNA data, MSigDB canonical pathways) Rau et al. (2020) Biostatistics
  15. 15 Integrative multi-omics methods: Clustering Clustering individuals based on single

    omics (especially gene expression) data widely used to identify molecular subtypes of cancer • PAM50, AIMS intrinsic subtypes • Many methods have been developed Recently, many integrative clustering methods have proposed to make use of multi-omic data • Rich literature in machine learning on multi-view methods • Multi-omic specific methods: MVDA, iCluster+, MOFA, … • Primarily de novo clustering from multi-omics data How can an existing clustering be merged or split based on multi-omics data? e.g., subdivide intrinsic subtypes into distinct sub-groups of individuals
  16. 16 maskmeans: Multi-view aggregation/splitting K-means = ( 1 , …

    , , …, ) where each is scaled to unit-variance and additionally divided by the size of its view: = / Aggregation/splitting of initial clustering of the n individuals based on the minimization of a criterion similar to the multi-view fuzzy K-means algorithm* with tuning parameters , > 1: * Wang and Chen (2017); Godichon-Baggioni et al. (2020) AOAS; http://github.com/andreamrau/maskmeans ෍ =1 ෍ =1 ෍ =1 (, )(, ) () − () 2 Clustering partition Per-view cluster centers Per-cluster, per-view weights
  17. 17 Multi-view splitting K-means algorithm Given a (hard or fuzzy)

    clustering matrix = (, ) with K clusters, at each step: Identify the cluster ෠ that minimizes our criterion Split this cluster in two, ሚ ෠ 1 and ሚ ෠ 2 , such that the criterion is minimized, under the constraint that ,1 + ,2 = ,෠ for all Update per-view cluster centers Update weight matrix = (, ) for this split for all = 1, … , and = 1, … , + 1 Godichon-Baggioni et al. (2020) AOAS 1 2 3 4 1 5 4 6 = 3 1 5
  18. n = 61 n = 38 n = 228 n

    = 136 n = 43 18 maskmeans for TCGA breast cancer n = 506 patients; focus on subset of 226 genes (TP53, MKI67, estrogen signaling and ErbB signaling pathways, and the SAM40 DNA methylation signature) and 149 miRNAs with avg normalized expression > 50 Godichon-Baggioni et al. (2020) AOAS Age at diagnosis + menopause status Number of lymph nodes
  19. Biology Statistics Visualize DE genes? Cluster expression profiles? Plot clusters

    in temporal order and output gene lists? Coordinates for open chromatin proximal to cluster 2? GO enrichment of genes proximal to accessible chromatin at t=2? 19
  20. Interactivity in (multi-omic) data analysis  Immediate feedback on how

    data/figures/results change when inputs are modified, user becomes an active participant in the analysis  Recent advances in R make interactive visualizations (plotly) and web applications (Shiny) more readily available  Shiny apps allow R scripts to be rerun based on user inputs without running R  Can be shared locally or hosted on the web (Shinyapps.io or using a Shiny server) 20
  21. 21 Regeneration Rosetta Shiny app * Expanded functionality beyond original

    study dozens of supported organisms, deep investigation of regeneration-associated expression and chromatin accessibility Dhara et al. (2019) Scientific Reports, doi: 10.1038/s41598-019-50485-6. Rau et al (2019). G3: Genes|Genomes|Genetics, doi: 10.1534/g3.119.400729, http://ls-shiny-prod.uwm.edu/rosetta {RNA-seq + ATAC-seq} x 5 time pts
  22. Some final remarks on multi-omics …and answering questions that we

    have not yet thought to ask1 Multi-omic data integration often requires a combination of software tools + technical expertise + domain expertise… Utility of tools for rapid querying + (interactive) exploration of fully processed data without advanced coding knowledge Reproducibility Communication + vocabulary is key! Emergence of single-cell multi-omics data2 and time-course multi- omics data 1 Stein-O’Brien et al. (2018) Trends in Genetics 2 Mathematical frameworks for integrative analysis of merging biological data types: https://www.birs.ca/events/2020/5-day-workshops/20w5197 Matrix factorization? Decomposition? Latent factor model? ...
  23. Acknowledgements 23 23 https://andrea-rau.com @andreamrau slides: https://tinyurl.com/JOBIM2020-Rau